Bowel Cancer or colorectal cancer is cancer that occurs in the colon or rectum. Sometimes it is called colon cancer, for short. Colorectal cancer is the second leading cancer killer in the United States, but it doesn’t have to be.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
The American Department of Health and Human Services has released a set of guidelines this Monday (12th November 2018) regarding the amount of exercise individuals need in order to stay healthy. The guidance is aimed at the sedentary population warning them of the ill effects of not being physically active.
Treating pre-cancerous stem cells at an early stage could be key to preventing bowel cancer in people born with a very high risk of the disease, according to a study in mice presented at the 2018 NCRI Cancer Conference.
Cancer patients could be spared unnecessary chemotherapy - and its side effects - by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.
An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.
Bowel Cancer UK, in partnership with the Royal College of Surgeons of Edinburgh, launch a £430,000 fundraising appeal for surgical bowel cancer research to establish Scotland’s first Colorectal Cancer Surgical Research Chair.
New research by Cardiff University has demonstrated a role for Aspirin in the treatment of bowel, prostate and breast cancer.
UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.
According to a report released by the World Health Organization’s cancer research agency this week, 9.6 million people would lose their lives to cancer this year. This translates as one in eight of all deaths and one in eleven of all deaths among men and women respectively says the agency.
Researchers at Queen's University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.
'Chromosomal catastrophes' have been found to occur along the evolutionary timeline of colorectal cancer development, according to new research led by Queen Mary University of London.
A team of researchers from Queen Mary University of London have reported the genetic events involved in the early development of bowel cancer in patients with inflammatory bowel disease.
A new clinical trial from the University of Leeds is testing omega-3 capsules in patients who have bowel cancer which has spread to the liver, to see if it can stop the cancer returning after surgery.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.
Bowel cancers affect thousands each year in Australia. Around 16,000 new diagnoses are made annually with huge number of people dying from this cancer. To curb the delayed diagnosis of bowel cancer that leads to less successful treatment outcomes, the Department of Health has been providing free, at-home testing kits for people aged between 50 and 75 years since 2006.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer -- cancer found on the descending section of the colon, where faeces is stored.
According to BBC newsreader George Alagiah, Scotland has better cancer screening procedures compared to England. Alagiah, a Sri Lankan born journalist, is 62 and is diagnosed with a stage 4 cancer of the bowel that relapsed little before Christmas. He says that his cancer would have been detected much earlier if he were being screened in Scotland rather than in England.
If first-degree relatives are affected by colorectal cancer, this indicates a person's own elevated risk of developing bowel cancer. The same holds true for people who have large numbers of genetic risk markers in their genome.
A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen's University Belfast highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.